FELTON, California, October 17, 2017 /PRNewswire/ --
Global clinical laboratory services marketsize was worth USD 186.1 billion in 2016 which is anticipated to grow at a CAGR of more than 6.3% over the forecast period. Clinical laboratories play a vital role in the healthcare industry as approximately 80% of clinician's
As the hospitalization period is getting smaller and communication period between clinicians and patients getting abridged, such amenities which collect, interpret, and provide specific information to clinicians are witnessing escalation in demand.
Several tests offered include routine blood and urine tests, sophisticated genetic examination, based on fluorescence in-situ hybridization and molecular expression testing to detect disease evolution and abnormalities.
Growing prevalence rates of chronic conditions, enhancing patient awareness and growth of geriatric population are the prominent drivers for clinical lab services market. Introduction of specialized diagnosis amenities for different pathological conditions such as endocrinology, oncology, and gynecology provide assistance to the physician in the detection and prevention of acute and chronic conditions thereby driving adoption rate.
Browse 155 page research report with TOC on "Global Clinical Laboratory Services Market" at: https://www.millioninsights.com/industry-reports/clinical-laboratory-services-market
Clinical laboratory services are segmented on the basis of different tests such as medical microbiology & cytology, clinical chemistry, human and tumor genetics, and esoteric tests. With the intensification of infectious conditions consequent upsurge in technique volumes is anticipated thereby influencing industrial growth.
In 2016, the market was dominated by clinical chemistry with a revenue share of approximately 45%. Increasing incidence of chronic conditions such as cardiovascular diseases, liver diseases, and blood disorders are attributive for the estimated share of the segment. In addition to this, rising demand for point of care testing (POCT) solutions for rapid testing is projected to promote the sector growth significantly.
Depending on the use of these services this sector is segmented into different types of labs including clinic based, hospital-based, and stand-alone laboratories. Hospital-based segment dominated with respect to revenue generation owing to factors such as the manifestation of high test volumes and high patient volumes are accountable for the largest segment share.
Stand-alone labs are anticipated to exhibit fastest YoY growth over the forecast years. Rising penetration of the stand-alone laboratories is anticipated to fuel the fastest growth in the segment in the coming years.
Drug discovery and drug development, toxicology testing, bioanalytical & lab chemistry, preclinical & clinical trial related services, and cell & gene therapy associated services are the application of these facilities.
Increasing awareness pertaining to disease diagnosis and usage of these services for advancement of health sciences and associated fields is expected to boost progress in this sector through to 2025.
North America accounted for the largest market revenue in such amenities in 2016 owing to the presence of advanced healthcare organization, promising reimbursement policies, and increasing incidence of chronic diseases.
Asia Pacific is anticipated to witness the fastest CAGR over the projected period. Advancements of healthcare services to fulfill the unmet needs of the clinicians are the factors which are driving the growth of lab-based facilities in developing economies such as China and India.
Major entities functioning in this market include Charles River Laboratories, Genzyme Corporation, Sonic Healthcare, Siemens Healthcare, Quest Diagnostics, Abbott Laboratories, Qiagen, Spectra Laboratories, ARUP Laboratories, and Genoptix Medical Laboratory.
Participants are actively undertaking initiatives for development of products and systems which will offer accurate patient sample results and allow thousands of samples to be processed simultaneously. Furthermore, key market players strategically collaborated with big healthcare organizations in order to ensure sustainability and widen the patient base.
Browse reports of similar category available with Million Insights:
Clinical Laboratory Services Test Type Outlook (Revenue, USD Billion; 2014-2025)
Human & Tumor Genetics Clinical Chemistry Medical Microbiology & Cytology Other Esoteric Tests
Clinical Laboratory Services Service Provider Outlook (Revenue, USD Billion; 2014-2025)
Hospital-Based Laboratories Stand-Alone Laboratories Clinic-Based Laboratories
Clinical Laboratory Services Application Outlook (Revenue, USD Billion; 2014-2025)
Drug discovery related Services Drug development related services Bioanalytical & Lab chemistry services Toxicology testing services Cell & gene therapy related services Preclinical & clinical trial related services Other clinical laboratory services
Clinical Laboratory Services Regional Outlook (Revenue, USD Billion; 2014-2025)
Middle East & Africa
About Million Insights:
Million Insights, is a distributor of market research reports, published by premium publishers only. We have a comprehensive market place, that will enable you to compare data points, before you make a purchase. Enabling informed buying, is our motto and we strive hard to ensure that our clients get to browse through multiple samples, prior to an investment. Service flexibility & the fastest response time are two pillars, on which our business model is founded. Our market research report store, includes in-depth reports, from across various industry verticals, such as healthcare, technology, chemicals, food & beverages, consumer goods, material science & automotive.
Contact: Ryan Manuel Research Support Specialist, USA Million Insights Phone: +1-408-610-2300 Toll Free: 1-866-831-4085 Email: [email protected]
SOURCE Million Insights
Subscribe to our Free Newsletters!
The state health insurance programs provide health care support to the below poverty line (BPL) ...
There is a lining between the lungs and chest wall known as Pleura. The dismissal of pleura by a ...
Reflux nephropathy is the scarring and damage caused to the kidneys by reverse flow of urine from ...View All